Perrigo Buys Rosemont Pharma For $283m

By Admin
Perrigo Co, a maker of generic and over-the-counter drugs, announced today that it bought UK-based Rosemont Pharmaceuticals for approximately $283 mil...

 

Perrigo Co, a maker of generic and over-the-counter drugs, announced today that it bought UK-based Rosemont Pharmaceuticals for approximately $283 million in cash to gain access to Rosemont's oral liquid formulations business.

The deal is expected to add 8 cents to Perrigo's adjusted earnings per share for the remainder of fiscal 2013, Perrigo said in a statement.

Perrigo now expects fiscal 2013 adjusted earnings of $5.53 to $5.73 per share.

Source: Reuters

Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance